Article 02 Aug 2024 "Can You Hear Me Now?": DOJ Expands Telehealth Enforcement Efforts United States Healthcare
Article 20 Jul 2023 CFPB, HHS, And Treasury Launch Inquiry Into Medical Payment Products United States Healthcare
Article 01 Feb 2023 Subpoenas At The Ready: The 118th Congress Is Poised To Investigate United States Government
Article 25 Nov 2021 Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know United States Healthcare
Article 03 May 2021 A New Federal Umpire: What Healthcare Providers Need To Know About Surprise Medical Billing Under The No Surprises Act United States Healthcare
Article 27 Nov 2020 HHS Finalizes New Protections For Value-Based Arrangements And Other Revisions To The Anti-Kickback Statute Safe Harbors And Civil Monetary Penalties Exceptions United States Healthcare
Article 25 Nov 2020 Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now United States Healthcare
Article 14 Nov 2020 Navigating The Post-Election Landscape: Life Sciences & Healthcare United States Healthcare
Article 04 Jun 2020 Navigating COVID-19 Related Congressional Investigations (Video) United States Coronavirus
Article 04 May 2020 Medicare And FCC Take Additional Steps To Support The Frontline Battling COVID-19 United States Healthcare
Article 29 Oct 2019 HHS Proposes New Protections For Value-Based Arrangements And Other Revisions To AKS Safe Harbors, CMP Exceptions And Stark Exceptions United States Healthcare
Article 11 Feb 2019 HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals United States Healthcare
Article 15 Jan 2019 Is DOJ Feeling Charitable? DOJ Files Statement Of Interest Regarding Manufacturer Donations To Charity Patient Assistance Programs United States Healthcare